Stay updated with breaking news from Nasdaq Trvn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a report published on Tuesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a buy rating and set a $9.00 target price on shares of Trevena in a report on Tuesday, April 2nd. Get Our Latest […]
StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a research report issued to clients and investors on Tuesday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a “buy” rating and set a $9.00 target price on shares of Trevena in a research report […]
Research analysts at StockNews.com started coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a research note issued on Monday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright restated a “buy” rating and set a $9.00 target price on shares of Trevena in a report on Tuesday, […]
Research analysts at StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reiterated a “buy” rating and set a $9.00 target price on shares of Trevena in […]
Trevena (NASDAQ:TRVN – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at HC Wainwright in a report released on Tuesday, Benzinga reports. They currently have a $9.00 price objective on the biopharmaceutical company’s stock. Separately, StockNews.com initiated coverage on Trevena in a research report on Friday. They set a “sell” rating […]